Charles Schwab Investment Management Inc. Boosts Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Charles Schwab Investment Management Inc. lifted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 12.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,710,938 shares of the company’s stock after buying an additional 290,019 shares during the quarter. Charles Schwab Investment Management Inc. owned about 0.59% of GE HealthCare Technologies worth $254,422,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Pathway Financial Advisers LLC purchased a new position in shares of GE HealthCare Technologies in the first quarter valued at $25,000. LGT Financial Advisors LLC boosted its stake in GE HealthCare Technologies by 1,673.3% in the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock worth $25,000 after purchasing an additional 251 shares during the period. Fred Alger Management LLC purchased a new position in GE HealthCare Technologies during the 2nd quarter valued at about $26,000. Capital Performance Advisors LLP bought a new stake in shares of GE HealthCare Technologies during the third quarter valued at about $26,000. Finally, Ashton Thomas Securities LLC purchased a new stake in shares of GE HealthCare Technologies in the third quarter worth about $26,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on GEHC shares. Wells Fargo & Company upped their target price on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a report on Thursday, October 31st. Evercore ISI increased their price objective on GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 1st. Redburn Atlantic raised GE HealthCare Technologies to a “strong-buy” rating in a research note on Thursday, August 1st. Stifel Nicolaus upped their target price on GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a “buy” rating in a research note on Monday, September 30th. Finally, BTIG Research upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price target for the company in a research report on Wednesday, September 18th. One investment analyst has rated the stock with a sell rating, five have given a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and an average target price of $94.36.

Insider Buying and Selling at GE HealthCare Technologies

In other news, CEO Roland Rott sold 3,577 shares of the firm’s stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total transaction of $309,338.96. Following the sale, the chief executive officer now owns 24,298 shares of the company’s stock, valued at $2,101,291.04. This trade represents a 12.83 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Price Performance

Shares of NASDAQ:GEHC opened at $82.44 on Friday. The business has a fifty day moving average price of $88.35 and a 200-day moving average price of $83.59. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98. The company has a market capitalization of $37.66 billion, a PE ratio of 22.65, a PEG ratio of 2.96 and a beta of 1.24. GE HealthCare Technologies Inc. has a 1-year low of $66.39 and a 1-year high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.06 by $0.08. The business had revenue of $4.86 billion during the quarter, compared to analysts’ expectations of $4.87 billion. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. During the same period in the previous year, the company earned $0.99 earnings per share. The business’s revenue for the quarter was up .9% compared to the same quarter last year. As a group, equities analysts expect that GE HealthCare Technologies Inc. will post 4.29 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were given a $0.03 dividend. The ex-dividend date was Friday, October 18th. This represents a $0.12 annualized dividend and a yield of 0.15%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.30%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.